期刊文献+

化浊祛痰消瘀法治疗慢性阻塞性肺疾病稳定期60例 被引量:4

Huazhuo Qutan Xiaoyu Method in the Treatment of Stable COPD for 60 Cases
下载PDF
导出
摘要 目的观察化浊祛痰消瘀法治疗慢性阻塞性肺病稳定期的疗效。方法将109例慢性阻塞性肺病急性缓解期患者随机分为两组,治疗组60例,对照组49例。治疗组在西医常规治疗基础上,同时给予化浊祛痰消瘀法治疗。对照组给予西医常规治疗。治疗1疗程后,观察比较两组的临床疗效和治疗前后主要症状、体征、血气分析、肺功能、C-反应蛋白等指标的变化。结果治疗组总有效率高于对照组,差异有显著性(P<0.05),同时治疗组上述多项指标的改善均优于对照组。结论化浊祛痰消瘀法治疗慢性阻塞性肺病稳定期有良好的治疗作用。 Objective To observe the effect of Huazhuo Qutan Xiaoyu method in the treatment of stable COPD. Methods 109 cases of patients with stable COPD were divied into treamet group of 60 cases and control group of 49 cases. The control group received routine treatment of Western medicine. On the basis of routine treatment of Western medicine, the treament group added with Huazhuo Qutan Xi-aoyu treatment. After one treatment course, the clinical effect, symptoms, physical signs, arterial blood gas analysis, pulmonary function and CRP before and after treatment were observed. Results The total effective rate of the treament group was better than that of the con-trol group, and the differences in symptoms, physical signs, arterial blood gas analysis, pulmonary function and CRP were statistical signif-icant(P〈0.05). Conclusion Huazhuo Qutan Xiaoyu method in the treatment of stable COPD had good effet.
作者 谢卫红 袁菲
出处 《中国中医药现代远程教育》 2015年第12期48-49,共2页 Chinese Medicine Modern Distance Education of China
关键词 慢性阻塞性肺病稳定期 化浊祛痰消瘀法 中医药疗法 喘证 stable COPD Huazhuo Qutan Xiaoyu method therapy of TCM syndrome characterized by dyspnea
  • 相关文献

参考文献6

二级参考文献26

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2钟小宁,郭韶梅.慢性支气管炎与肺气肿大鼠肺血管炎症的实验研究[J].中华结核和呼吸杂志,2006,29(7):435-439. 被引量:22
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 4HurstJR,WilkinsonTMA,PereraWR,eta1.Relationshipsamongbacteria,upperairway,lowerairway,andsystemicinflammationinCOPD[J].Chest,2005,127:1219-1226.
  • 5MercerPF,ShuteJK,BhowmikA,eta1.MMP-9,TIMP一1andinflammatorycellsinsputumfxomCOPDpatientsduringexacerbation[J].RespirRes,2005,6(1):151.
  • 6PeraT,ValadasJZuidhofAB.TiotropiuminhibitspulmonaryvascularremodelinginaguineapigmodelofCOPD[J].AmJRespirCritCareMed,2010,181(5):A1193.
  • 7中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治南(2007年修订版).中华结核和呼吸杂志,2007,:33-36.
  • 8GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 9Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 10Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.

共引文献8282

同被引文献57

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部